{"id":3600,"date":"2020-10-01T12:56:38","date_gmt":"2020-10-01T16:56:38","guid":{"rendered":"https:\/\/www.gensight-biologics.com\/ophthalmology-futures-retina-forum-virtuel\/"},"modified":"2026-07-15T15:57:40","modified_gmt":"2026-07-15T19:57:40","slug":"ophthalmology-futures-retina-forum-virtuel","status":"publish","type":"post","link":"https:\/\/www.gensight-biologics.com\/fr\/2020\/10\/01\/ophthalmology-futures-retina-forum-virtuel\/","title":{"rendered":"Ophthalmology Futures Retina &#8211; Forum virtuel"},"content":{"rendered":"\n<strong>Magali Taiel<\/strong>, Directeur M\u00e9dical, pr\u00e9sentera la soci\u00e9t\u00e9 au Forum virtuel <a href=\"https:\/\/www.ophthalmology-futures.com\/forums\/\" target=\"_blank\" rel=\"noopener\"><strong>Ophthalmology Futures Retina<\/strong><\/a> ainsi que les derniers r\u00e9sultats cliniques de son traitement principal de th\u00e9rapie g\u00e9nique LUMEVOQ\u00ae (GS010) pour traiter la NOHL, qui a \u00e9t\u00e9 soumis pour autorisation de mise sur le march\u00e9 en Europe en septembre 2020.\n<ul>\n \t<li>Session : Company Presentations 2<\/li>\n \t<li>Heure : 17h30 \u2013 18h30 heure locale (CEST)<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Magali Taiel, Directeur M\u00e9dical, pr\u00e9sentera la soci\u00e9t\u00e9 au Forum virtuel Ophthalmology Futures Retina ainsi que les derniers r\u00e9sultats cliniques de son traitement principal de th\u00e9rapie g\u00e9nique LUMEVOQ\u00ae (GS010) pour traiter la NOHL, qui a \u00e9t\u00e9 soumis pour autorisation de mise sur le march\u00e9 en Europe en septembre 2020. Session : Company Presentations 2 Heure : [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[55],"tags":[],"featured-area":[],"news-topic":[73,79],"news-type":[74,75,77],"post-year":[],"class_list":["post-3600","post","type-post","status-publish","format-standard","hentry","category-evenements","news-topic-gs010-lumevoq","news-topic-company-and-personnel","news-type-product-candidates","news-type-clinical","news-type-conferences"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ophthalmology Futures Retina - Forum virtuel - GenSight Biologics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2020\/10\/01\/ophthalmology-futures-retina-forum-virtuel\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ophthalmology Futures Retina - Forum virtuel - GenSight Biologics\" \/>\n<meta property=\"og:description\" content=\"Magali Taiel, Directeur M\u00e9dical, pr\u00e9sentera la soci\u00e9t\u00e9 au Forum virtuel Ophthalmology Futures Retina ainsi que les derniers r\u00e9sultats cliniques de son traitement principal de th\u00e9rapie g\u00e9nique LUMEVOQ\u00ae (GS010) pour traiter la NOHL, qui a \u00e9t\u00e9 soumis pour autorisation de mise sur le march\u00e9 en Europe en septembre 2020. Session : Company Presentations 2 Heure : [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gensight-biologics.com\/fr\/2020\/10\/01\/ophthalmology-futures-retina-forum-virtuel\/\" \/>\n<meta property=\"og:site_name\" content=\"GenSight Biologics\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-01T16:56:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-15T19:57:40+00:00\" \/>\n<meta name=\"author\" content=\"jbenedicto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"jbenedicto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/10\\\/01\\\/ophthalmology-futures-retina-forum-virtuel\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/10\\\/01\\\/ophthalmology-futures-retina-forum-virtuel\\\/\"},\"author\":{\"name\":\"jbenedicto\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"headline\":\"Ophthalmology Futures Retina &#8211; Forum virtuel\",\"datePublished\":\"2020-10-01T16:56:38+00:00\",\"dateModified\":\"2026-07-15T19:57:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/10\\\/01\\\/ophthalmology-futures-retina-forum-virtuel\\\/\"},\"wordCount\":68,\"articleSection\":[\"Evenements\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/10\\\/01\\\/ophthalmology-futures-retina-forum-virtuel\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/10\\\/01\\\/ophthalmology-futures-retina-forum-virtuel\\\/\",\"name\":\"Ophthalmology Futures Retina - Forum virtuel - GenSight Biologics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-10-01T16:56:38+00:00\",\"dateModified\":\"2026-07-15T19:57:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/10\\\/01\\\/ophthalmology-futures-retina-forum-virtuel\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/10\\\/01\\\/ophthalmology-futures-retina-forum-virtuel\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2020\\\/10\\\/01\\\/ophthalmology-futures-retina-forum-virtuel\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ophthalmology Futures Retina &#8211; Forum virtuel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"name\":\"GenSight Biologics\",\"description\":\"Restoring vision while advancing gene therapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\",\"name\":\"jbenedicto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"caption\":\"jbenedicto\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ophthalmology Futures Retina - Forum virtuel - GenSight Biologics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gensight-biologics.com\/fr\/2020\/10\/01\/ophthalmology-futures-retina-forum-virtuel\/","og_locale":"fr_FR","og_type":"article","og_title":"Ophthalmology Futures Retina - Forum virtuel - GenSight Biologics","og_description":"Magali Taiel, Directeur M\u00e9dical, pr\u00e9sentera la soci\u00e9t\u00e9 au Forum virtuel Ophthalmology Futures Retina ainsi que les derniers r\u00e9sultats cliniques de son traitement principal de th\u00e9rapie g\u00e9nique LUMEVOQ\u00ae (GS010) pour traiter la NOHL, qui a \u00e9t\u00e9 soumis pour autorisation de mise sur le march\u00e9 en Europe en septembre 2020. Session : Company Presentations 2 Heure : [&hellip;]","og_url":"https:\/\/www.gensight-biologics.com\/fr\/2020\/10\/01\/ophthalmology-futures-retina-forum-virtuel\/","og_site_name":"GenSight Biologics","article_published_time":"2020-10-01T16:56:38+00:00","article_modified_time":"2026-07-15T19:57:40+00:00","author":"jbenedicto","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"jbenedicto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/10\/01\/ophthalmology-futures-retina-forum-virtuel\/#article","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/10\/01\/ophthalmology-futures-retina-forum-virtuel\/"},"author":{"name":"jbenedicto","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"headline":"Ophthalmology Futures Retina &#8211; Forum virtuel","datePublished":"2020-10-01T16:56:38+00:00","dateModified":"2026-07-15T19:57:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/10\/01\/ophthalmology-futures-retina-forum-virtuel\/"},"wordCount":68,"articleSection":["Evenements"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/10\/01\/ophthalmology-futures-retina-forum-virtuel\/","url":"https:\/\/www.gensight-biologics.com\/fr\/2020\/10\/01\/ophthalmology-futures-retina-forum-virtuel\/","name":"Ophthalmology Futures Retina - Forum virtuel - GenSight Biologics","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#website"},"datePublished":"2020-10-01T16:56:38+00:00","dateModified":"2026-07-15T19:57:40+00:00","author":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"breadcrumb":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/10\/01\/ophthalmology-futures-retina-forum-virtuel\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gensight-biologics.com\/fr\/2020\/10\/01\/ophthalmology-futures-retina-forum-virtuel\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.gensight-biologics.com\/fr\/2020\/10\/01\/ophthalmology-futures-retina-forum-virtuel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gensight-biologics.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"Ophthalmology Futures Retina &#8211; Forum virtuel"}]},{"@type":"WebSite","@id":"https:\/\/www.gensight-biologics.com\/fr\/#website","url":"https:\/\/www.gensight-biologics.com\/fr\/","name":"GenSight Biologics","description":"Restoring vision while advancing gene therapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gensight-biologics.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f","name":"jbenedicto","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","caption":"jbenedicto"}}]}},"_links":{"self":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/3600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/comments?post=3600"}],"version-history":[{"count":0,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/3600\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/media?parent=3600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/categories?post=3600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/tags?post=3600"},{"taxonomy":"featured-area","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/featured-area?post=3600"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-topic?post=3600"},{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-type?post=3600"},{"taxonomy":"post-year","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/post-year?post=3600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}